Expert Rev Cardiovasc Ther. 2009 Mar;7(3):273-80.

Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.

Source

Division of Cardiology, University of California-Irvine Medical Center, 101 City Drive South, Orange, CA 92868, USA. smalik@uci.edu

Abstract

The metabolic syndrome is a clustering of risk factors known to promote or increase the risk of diabetes development and subsequent cardiovascular disease. Screening for subclinical atherosclerosis using new imaging technologies or novel biomarkers could help to further risk-stratify patients with metabolic syndrome. In particular, noninvasive imaging of carotid intima-media thickness and coronary artery calcium scoring seem to have promising prognostic value in identifying patients at high risk. Early identification could lead to improved patient or physician adherence to risk-reducing behaviors or interventions and improve clinical outcomes.

PMID:: 19296765; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

CALCIUM, ELEMENTAL - HSDB

Supplemental Content

Related citations

Review Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. [J Hypertens. 2002]
Review Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence.
Bots ML, Dijk JM, Oren A, Grobbee DE. J Hypertens. 2002 Dec; 20(12):2317-25.
Review Carotid intima-media thickness and cardiovascular risk. [Future Cardiol. 2011]
Review Carotid intima-media thickness and cardiovascular risk.
Mookadam F, Tanasunont W, Jalal U, Mookadam M, Wilansky S. Future Cardiol. 2011 Mar; 7(2):173-82.
Review Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. [Am J Cardiol. 2004]
Review Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy.
Rajaram V, Pandhya S, Patel S, Meyer PM, Goldin M, Feinstein MJ, Neems R, Liebson PR, Fiedler BM, Macioch JE, et al. Am J Cardiol. 2004 Jun 3; 93(11A):32C-48C.
Review Vascular preventive measures: the progression from asymptomatic to symptomatic atherosclerosis management. Evidence on usefulness of early diagnosis in women and children. [Future Cardiol. 2010]
Review Vascular preventive measures: the progression from asymptomatic to symptomatic atherosclerosis management. Evidence on usefulness of early diagnosis in women and children.
Rubba F, Gentile M, Iannuzzi A, Panico S, Mattiello A, Quagliata L, Triassi M, Rubba P. Future Cardiol. 2010 Mar; 6(2):211-20.
[Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus]. [Ann Acad Med Stetin. 2008]
[Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
Fischer K. Ann Acad Med Stetin. 2008; 54(2):22-32.

See reviews... See all...

Cited by 1 PubMed Central article

The association between Type D personality and the metabolic syndrome: a cross-sectional study in a University-based outpatient lipid clinic. [BMC Res Notes. 2011]
The association between Type D personality and the metabolic syndrome: a cross-sectional study in a University-based outpatient lipid clinic.
Tziallas D, Kostapanos MS, Skapinakis P, Milionis HJ, Athanasiou T, S Elisaf M, Mavreas V. BMC Res Notes. 2011 Apr 5; 4:105. Epub 2011 Apr 5.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Metabolic syndrome, cardiovascular risk and screening for subclinical atheroscle...
Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.
Expert Rev Cardiovasc Ther. 2009 Mar ;7(3):273-80.

PubMed
Metabolic syndrome: at the crossroads of cardiorenal risk.
Metabolic syndrome: at the crossroads of cardiorenal risk.
J Nephrol. 2009 Jan-Feb ;22(1):29-38.

PubMed
Tetrodotoxin poisoning.
Tetrodotoxin poisoning.
Adv Food Nutr Res. 2007 ;52:141-236.

PubMed
Clinical efficacy of three common treatments in acute otitis externa in primary ...
Clinical efficacy of three common treatments in acute otitis externa in primary care: randomised controlled trial.
BMJ. 2003 Nov 22 ;327(7425):1201-5.

PubMed
Caspase cleavage product of BAP31 induces mitochondrial fission through endoplas...
Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol.
J Cell Biol. 2003 Mar 31 ;160(7):1115-27.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information